Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

NCT04733768 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04733768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04733768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2021
Completion date
August 9, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer